AC Immune SG&A Expense (Quarterly) Trends

AC Immune SA (ACIU)

2.38 -0.02 (-0.83%) USD | NASDAQ | May 07, 16:00

2.38 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2015. Upgrade now.

Date	Value
December 31, 2023	-0.7628M
September 30, 2023	3.924M
June 30, 2023	4.095M
March 31, 2023	4.434M
December 31, 2022	-2.334M
September 30, 2022	3.39M
June 30, 2022	4.532M
March 31, 2022	4.510M
December 31, 2021	-4.463M
September 30, 2021	5.904M
June 30, 2021	5.748M
March 31, 2021	4.796M
December 31, 2020	-2.730M
September 30, 2020	5.320M
June 30, 2020	4.312M
March 31, 2020	4.655M
December 31, 2019	-1.428M
September 30, 2019	4.015M

Date	Value
June 30, 2019	3.575M
March 31, 2019	3.306M
December 31, 2018	-1.144M
September 30, 2018	2.978M
June 30, 2018	3.112M
March 31, 2018	2.858M
December 31, 2017	-0.7889M
September 30, 2017	2.617M
June 30, 2017	2.201M
March 31, 2017	2.376M
December 31, 2016	0.2638M
September 30, 2016	1.756M
June 30, 2016	1.906M
March 31, 2016	0.9049M
December 31, 2015	-0.4631M
September 30, 2015	0.9224M
June 30, 2015	0.59M
March 31, 2015	0.4516M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

-4.463M

Minimum

Dec 2021

5.904M

Maximum

Sep 2021

2.710M

Average

4.095M

Median

Jun 2023

SG&A Expense (Quarterly) Benchmarks